>
After Years Of Delays, Aptera Is Finally Preparing To Build Customer Cars
The Iran off-ramp Trump keeps driving past
Free Trade: The Consensus Is Growing
Netanyahu says no Israeli withdrawal from Gaza until Hamas has been completely disarmed
Voyager 1 approaches one light day from Earth
Renewable Energy Breakthrough! World's Most Efficient Tesla Turbine System
Meet Sunbird, a nuclear fusion-powered space tug concept from Pulsar Fusion.
China and Russia launch 29-nation AI alliance to rival western control of technology
BREAKING: China has begun manufacturing domestically developed Immersion Deep...
Idaho's High Desert Becomes Hot Spot For Nuclear Power Revolution
The World's Largest Electric Aircraft Is About to Take Its First Flight
Tesla Cybercabs and Superchargers Will Act as Mini Cell Towers for SpaceX Starlink

MIT Technology Review reports that the first use of CRISPR in humans, to edit immune cells, has been proposed by scientists at the University of Pennsylvania. The National Institutes of Health's Recombinant DNA Advisory Committee will meet next week to review the the use of the technology.
The NIH writes in a blog post that the technique would be used to edit two genes in human T cells, which would target myeloma, melanoma, and sarcoma tumor cells.
This comes after an earlier proposal from Editas, a biotech company that plans to use CRISPR to treat eye disorders in 2017.